Hello all:
S.V..P. Politics regardless of stripes is s no win argument.
I'd rather we banter around our ONC possibilities, sucseses ' or failures l be it clinical or business.
We have two very important events happening very soon.
The JPmrorgan conference is tomorrow ( Monday 2:30 pacific time), My understanding after markets are closed.
Will they, go over the existing on- line investor presentation? With a Q & A ?
Will they add some additional business discussions?
Resding the promotional materials, the organizers make it clear many of the deals/ discussions etc happen outside of the formal presentation time slots.
The other upcoming events is the January 25th global cancer conference.
I understand they have two presentations.
The second being the newest & significant.
They said in the yeare end uodate, they intend to report of efficacy resukts from the anal cancer co- therapy trial with Roche.
To the best of my knowledge that information is under embargo until the 20th.
As an investor & I know shared by others, I hope that the results as a minimum lead to a third registration enabling trial.
in essence creating a solid reason to aquire ONC outright.
One thing is obvious, they are putting a strong focus on brining this to a posituve outcome.
has been a very long road.
All the best everyone.
cf